Loading...

Home
ETF
RADX

RADX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

RADX News

Radiopharm Theranostics Reports Interim Clinical Trial Results and Financial Update

Jan 28 2026Newsfilter

Benzinga Market Update: Carnival, Caterpillar, Meta Among Stocks as Markets See Slight Increases

Dec 20 2025Benzinga

Dow Declines by 50 Points; US Employment Increases by 64,000 in November

Dec 16 2025Benzinga

B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading

Dec 16 2025Benzinga

What’s Behind the 140% Surge in Radiopharm Theranostics Stock?

Dec 15 2025Benzinga

Radiopharm's RAD 101 Achieves 92% MRI Concordance in Phase 2b Trial

Dec 15 2025Newsfilter

Radiopharm Theranostics Granted Approval to Start Phase 1 Clinical Trial of RAD 402 (KLK3-mAb with Tb161) for Advanced Prostate Cancer

Nov 18 2025Newsfilter

Deutsche Bank ADR Virtual Investor Conference: Presentations Accessible for Online Viewing

Nov 05 2025Globenewswire

UPDATE -- Global Firms to Present Live Webcasts at Deutsche Bank’s Virtual Investor Conference for Depositary Receipts on November 4, 2025

Oct 31 2025Globenewswire

Global Firms to Present Live Webcasts at Deutsche Bank's Virtual Investor Conference for Depositary Receipts on November 4, 2025

Oct 30 2025Globenewswire

Radiopharm Theranostics Gets Green Light from Data Safety and Monitoring Committee to Fast-Track 177Lu-RAD202 Phase 1 'HEAT' Dose Escalation Clinical Trial

Oct 01 2025Newsfilter

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Jul 29 2025Newsfilter

Radiopharm Reports FDA Clearance To Initiate First-in-human Phase 1 Trial Of RV-01

Jul 28 2025NASDAQ.COM

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Jul 22 2025Newsfilter

Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Jun 04 2025Newsfilter

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

May 19 2025Newsfilter